Tumor stroma as contributing factor in the lymph node metastases process?
作者信息
Mesker Wilma E, van Pelt Gabi W, Tollenaar Rob A E M
机构信息
Wilma E. Mesker: Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands.
出版信息
Oncotarget. 2019 Jan 29;10(9):922-923. doi: 10.18632/oncotarget.26644.
Abstract
摘要
相似文献
1
Tumor stroma as contributing factor in the lymph node metastases process?肿瘤基质是淋巴结转移过程中的促成因素？
Oncotarget. 2019 Jan 29;10(9):922-923. doi: 10.18632/oncotarget.26644.
2
Expression of hypoxia-associated proteins in sporadic medullary thyroid cancer is associated with desmoplastic stroma reaction and lymph node metastasis and may indicate somatic mutations in the VHL gene.散发性髓样甲状腺癌中缺氧相关蛋白的表达与纤维母细胞性基质反应和淋巴结转移相关，并可能提示 VHL 基因的体细胞突变。
J Pathol. 2011 Sep;225(1):63-72. doi: 10.1002/path.2926. Epub 2011 Jun 1.
3
Clinical implications of the histologically and immunohistochemically detected solitary lymph node metastases in gastric cancer.胃癌组织学和免疫组织化学检测到的孤立淋巴结转移的临床意义。
Scand J Surg. 2011;100(3):174-80. doi: 10.1177/145749691110000307.
4
The distribution of lymph node metastases and their size in colon cancer.结肠癌中淋巴结转移的分布情况及其大小
Langenbecks Arch Surg. 2017 Dec;402(8):1213-1221. doi: 10.1007/s00423-017-1628-z. Epub 2017 Oct 5.
5
Management of the lymph nodes in penile cancer.阴茎癌的淋巴结管理。
Urology. 2010 Aug;76(2 Suppl 1):S43-57. doi: 10.1016/j.urology.2010.03.001.
6
Molecular genetic changes in metastatic primary Barrett's adenocarcinoma and related lymph node metastases: comparison with nonmetastatic Barrett's adenocarcinoma.转移性原发性巴雷特腺癌及相关淋巴结转移的分子遗传学改变：与非转移性巴雷特腺癌的比较。
Mod Pathol. 2000 Jul;13(7):814-24. doi: 10.1038/modpathol.3880143.
7
Staging of gastric cancer: correlation of lymph node size and metastatic infiltration.胃癌分期：淋巴结大小与转移浸润的相关性
AJR Am J Roentgenol. 1999 Aug;173(2):365-7. doi: 10.2214/ajr.173.2.10430138.
8
Preoperative sonographic classification of axillary lymph nodes in patients with breast cancer: node-to-node correlation with surgical histology and sentinel node biopsy results.术前超声对乳腺癌腋窝淋巴结的分类：与手术组织学和前哨淋巴结活检结果的淋巴结间相关性。
AJR Am J Roentgenol. 2009 Dec;193(6):1731-7. doi: 10.2214/AJR.09.3122.
9
Complete axillary lymph node dissection for stage I-II carcinoma of the breast.对Ⅰ-Ⅱ期乳腺癌患者行腋窝淋巴结清扫术。
J Clin Oncol. 1986 May;4(5):655-62. doi: 10.1200/JCO.1986.4.5.655.
10
[Metastasis rates of lymph nodes and distribution in advanced gastric cancer and its clinical significance].[进展期胃癌淋巴结转移率及分布情况及其临床意义]
Zhonghua Wei Chang Wai Ke Za Zhi. 2006 Nov;9(6):506-9.
引用本文的文献
1
Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma.未经治疗的转移性恶性黑色素瘤的蛋白质基因组分析
Cancers (Basel). 2025 Feb 27;17(5):832. doi: 10.3390/cancers17050832.
2
Exploring the Complex and Multifaceted Interplay between Melanoma Cells and the Tumor Microenvironment.探索黑色素瘤细胞与肿瘤微环境之间复杂且多方面的相互作用。
Int J Mol Sci. 2023 Sep 21;24(18):14403. doi: 10.3390/ijms241814403.
3
Characteristics of tumour stroma in regional lymph node metastases in colorectal cancer patients: a theoretical framework for future diagnostic imaging with FAPI PET/CT.结直肠癌患者区域淋巴结转移中肿瘤基质的特征：FAPI PET/CT 未来诊断成像的理论框架。
Clin Transl Oncol. 2022 Sep;24(9):1776-1784. doi: 10.1007/s12094-022-02832-9. Epub 2022 Apr 28.
4
Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic marker.基于质谱的福尔马林固定、石蜡包埋的远端胆管癌分析鉴定出基质血栓调节蛋白-2 作为一种潜在的预后标志物。
J Transl Med. 2020 Sep 4;18(1):343. doi: 10.1186/s12967-020-02498-3.
本文引用的文献
1
Variability in HER2 expression between primary colorectal cancer and corresponding metastases.原发性结直肠癌与相应转移灶中 HER2 表达的变异性。
J Cancer Res Clin Oncol. 2018 Nov;144(11):2275-2281. doi: 10.1007/s00432-018-2744-z. Epub 2018 Sep 10.
2
Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations.结肠癌中肿瘤间质比的评分：操作步骤与建议。
Virchows Arch. 2018 Oct;473(4):405-412. doi: 10.1007/s00428-018-2408-z. Epub 2018 Jul 20.
3
The prognostic value of tumor-stroma ratio in tumor-positive axillary lymph nodes of breast cancer patients.肿瘤-基质比率在乳腺癌患者肿瘤阳性腋窝淋巴结中的预后价值。
Int J Cancer. 2018 Dec 15;143(12):3194-3200. doi: 10.1002/ijc.31658. Epub 2018 Oct 16.
4
The tumour-stroma ratio in colon cancer: the biological role and its prognostic impact.结直肠癌的肿瘤间质比：生物学作用及其预后影响。
Histopathology. 2018 Aug;73(2):197-206. doi: 10.1111/his.13489. Epub 2018 Mar 24.
5
Genetic dissimilarity between primary colorectal carcinomas and their lymph node metastases: ploidy, p53, bcl-2, and c-myc expression--a pilot study.原发性结直肠癌与其淋巴结转移灶之间的基因差异：倍体、p53、bcl-2和c-myc表达——一项初步研究。
Tumour Biol. 2015 Aug;36(8):6579-84. doi: 10.1007/s13277-015-3353-y. Epub 2015 Apr 4.
6
Environment-mediated drug resistance: a major contributor to minimal residual disease.环境介导的耐药性：微小残留病的主要促成因素。
Nat Rev Cancer. 2009 Sep;9(9):665-74. doi: 10.1038/nrc2714. Epub 2009 Aug 20.
7
The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage.与淋巴结状态和肿瘤分期相比，结肠癌的癌间质比是生存的独立因素。
Cell Oncol. 2007;29(5):387-98. doi: 10.1155/2007/175276.
8
Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases.
Eur J Cancer. 2002 Nov;38(17):2258-64. doi: 10.1016/s0959-8049(02)00234-4.
Zotero 插件